These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
550 related items for PubMed ID: 22593565
1. Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones. Ammann D, McLaren JM, Gerostamoulos D, Beyer J. J Anal Toxicol; 2012 Jul; 36(6):381-9. PubMed ID: 22593565 [Abstract] [Full Text] [Related]
2. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids. Ammann J, McLaren JM, Gerostamoulos D, Beyer J. J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567 [Abstract] [Full Text] [Related]
3. Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis. Swortwood MJ, Boland DM, DeCaprio AP. Anal Bioanal Chem; 2013 Feb; 405(4):1383-97. PubMed ID: 23180084 [Abstract] [Full Text] [Related]
4. Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry. Pasin D, Bidny S, Fu S. J Anal Toxicol; 2015 Apr; 39(3):163-71. PubMed ID: 25552261 [Abstract] [Full Text] [Related]
5. Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. Marinetti LJ, Antonides HM. J Anal Toxicol; 2013 Apr; 37(3):135-46. PubMed ID: 23361867 [Abstract] [Full Text] [Related]
6. Detection and validated quantification of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, tadalafil, and 2 of their metabolites in human blood plasma by LC-MS/MS--application to forensic and therapeutic drug monitoring cases. Rust KY, Wilkens H, Kaiser R, Bregel D, Wilske J, Kraemer T. Ther Drug Monit; 2012 Dec; 34(6):729-35. PubMed ID: 23128911 [Abstract] [Full Text] [Related]
7. Sensitive hydrophilic interaction liquid chromatography/tandem mass spectrometry method for rapid detection, quantification and confirmation of cathinone-derived designer drugs for doping control in equine plasma. Li X, Uboh CE, Soma LR, Liu Y, Guan F, Aurand CR, Bell DS, You Y, Chen J, Maylin GA. Rapid Commun Mass Spectrom; 2014 Jan 30; 28(2):217-29. PubMed ID: 24338970 [Abstract] [Full Text] [Related]
8. Detection of gamma-hydroxybutyrate in hair: validation of GC-MS and LC-MS/MS methods and application to a real case. Bertol E, Argo A, Procaccianti P, Vaiano F, Di Milia MG, Furlanetto S, Mari F. J Pharm Biomed Anal; 2012 Nov 30; 70():518-22. PubMed ID: 22884787 [Abstract] [Full Text] [Related]
9. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry. Gottardo R, Bortolotti F, De Paoli G, Pascali JP, Miksík I, Tagliaro F. J Chromatogr A; 2007 Aug 03; 1159(1-2):185-9. PubMed ID: 17240388 [Abstract] [Full Text] [Related]
10. Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization. Beyer J, Peters FT, Kraemer T, Maurer HH. J Mass Spectrom; 2007 Feb 03; 42(2):150-60. PubMed ID: 17154352 [Abstract] [Full Text] [Related]
11. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". Coppola M, Mondola R. Toxicol Lett; 2012 Jun 01; 211(2):144-9. PubMed ID: 22459606 [Abstract] [Full Text] [Related]
12. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. J Mass Spectrom; 2003 Jun 01; 38(6):659-76. PubMed ID: 12827635 [Abstract] [Full Text] [Related]
13. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers. Pichini S, Pujadas M, Marchei E, Pellegrini M, Fiz J, Pacifici R, Zuccaro P, Farré M, de la Torre R. J Pharm Biomed Anal; 2008 Jun 09; 47(2):335-42. PubMed ID: 18262381 [Abstract] [Full Text] [Related]
14. Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. Sørensen LK. J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr 01; 879(11-12):727-36. PubMed ID: 21376674 [Abstract] [Full Text] [Related]
15. Screening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry system. O'Byrne PM, Kavanagh PV, McNamara SM, Stokes SM. J Anal Toxicol; 2013 Mar 01; 37(2):64-73. PubMed ID: 23316030 [Abstract] [Full Text] [Related]
18. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. Habrdova V, Peters FT, Theobald DS, Maurer HH. J Mass Spectrom; 2005 Jun 01; 40(6):785-95. PubMed ID: 15827969 [Abstract] [Full Text] [Related]
19. Quantitative analysis of 3,4-dimethylmethcathinone in blood and urine by liquid chromatography-tandem mass spectrometry in a fatal case. Usui K, Aramaki T, Hashiyada M, Hayashizaki Y, Funayama M. Leg Med (Tokyo); 2014 Jul 01; 16(4):222-6. PubMed ID: 24780695 [Abstract] [Full Text] [Related]
20. Simultaneous determination of new thioamphetamine designer drugs in plasma by capillary electrophoresis coupled with mass spectrometry. Boatto G, Nieddu M, Pirisi MA, Dessì G. Rapid Commun Mass Spectrom; 2007 Jul 01; 21(22):3716-20. PubMed ID: 17955568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]